CERT on XNAS, Technology, Certara, Inc., job postings
Measures activity, not value. Not investment advice.
Quarterly revenue fell 9.3% to $94.9M, but the stock is up 101% in six months.
BadShort interest at 17% of shares, with 11.6 days to cover
WatchFree cash flow of $78.2M over 12 months despite a $64.3M net loss
Written by AI from the data on this page, 22 Nov 2026. Not investment advice.
Profile and fundamentals
From its SEC filings, 12 months to 30 Sep 2026
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval, and increase patient access to medicines. The company has its business presence in the Americas, which is also its key revenue-generating market, EMEA, and the Asia Pacific region.
expected around 25 Feb 2027 (an estimate: a year ago it reported on 26 Feb 2026)
Revenue and net income per quarter. Quarter to 30 Sep 2026: revenue $94.9M, net income $5.6M.
31 Dec 2021RevenueNet incomeNet losstallest bar $106.9M30 Sep 2026
See the numbers
Quarter to
Revenue
Net income
30 Sep 2026
$94.9M
$5.6M
30 Jun 2026
$93.3M
-$55.3M
31 Mar 2026
$106.9M
-$8.8M
31 Dec 2025
$103.6M
-$5.9M
30 Sep 2025
$104.6M
$1.5M
30 Jun 2025
$104.6M
-$2.0M
31 Mar 2025
$106.0M
$4.7M
31 Dec 2024
$100.4M
$6.6M
30 Sep 2024
$94.8M
-$1.4M
30 Jun 2024
$93.3M
-$12.6M
31 Mar 2024
$96.7M
-$4.7M
31 Dec 2023
$88.0M
-$12.5M
30 Sep 2023
$85.6M
-$49.0M
30 Jun 2023
$90.5M
$4.7M
31 Mar 2023
$90.3M
$1.4M
31 Dec 2022
$86.6M
$9.2M
30 Sep 2022
$84.7M
$3.9M
30 Jun 2022
$82.8M
-$589K
31 Mar 2022
$81.6M
$2.2M
31 Dec 2021
$75.3M
-$9.7M
Fundamentals, 12 months to 30 Sep 2026
Measure
Latest
Year before
Peer median
RevenueiSales over the last 12 months reported.
$398.7M
$389.6M
Revenue growthiRevenue of the last 12 months compared with the 12 months before.
+2.3%
+13%
Net incomeiProfit after all costs and taxes over the last 12 months reported. Negative is a loss.
-$64.3M
$10.9M
EPS (diluted)iEarnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split).
-$0.42
$0.07
Gross marginiWhat is left of each dollar of sales after the direct cost of making the product or service.
–
–
72.5%
Operating marginiOperating income as a share of sales: profit from the business before interest and taxes.
-0.3%
5.3%
-0.3%
Net marginiNet income as a share of sales: what the owners keep of each dollar sold.
-16.1%
2.8%
0.8%
Return on equityiNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money.
-6.3%
1.0%
Free cash flowiCash from operations minus capital spending over the last 12 months: cash the business produced.
$78.2M
–
CashiCash, cash equivalents and short-term investments on the latest balance sheet.
$214.9M
$172.7M
DebtiShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted.
$291.2M
$293.5M
Net debtiDebt minus cash. Negative means the company holds more cash than it owes (net cash).
$76.3M
$120.8M
Debt to equityiDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative.
0.30
0.32
Book value per shareiShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding.
$6.41
P/EiPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss.
loss
42.2
P/SiPrice to sales: market cap divided by revenue of the last 12 months.
4.0
3.4
EV/SalesiEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months.
4.2
3.8
P/BiPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative.
1.6
3.7
Latest = 12 months to 30 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.
Peers nearest by market cap, its own industry first
Insider Buy/Sell iShares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.
–
No data for this company
Institutional holders iThe number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.
+3.8%
246 13F filers vs 237
Institutional ownership iShares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.
89%
136.0M shares held by 13F filers (30 Sep 2026) of 152.5M outstanding (1 Nov 2026)
Short interest iShares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.
17%
25.5M shares sold short (30 Oct 2026) of 152.5M outstanding (1 Nov 2026)
Days to cover iShort interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.
11.6
25.5M shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it
Short interest change iHow the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.
-0.6%
25.7M shares sold short in the report before, 25.5M on 30 Oct 2026
Short sale volume iShare of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.
67%
67% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 51%
Open jobs iJob postings open on the company's own careers site today, where we track it. Blank when we do not track this company's careers site yet.
53
Tracked since 21 Nov 2026
Open jobs change iHow the number of open job postings changed over the last 30 days: total hiring demand, any job, any country. Shown only once we have tracked the company for 30 days.
–
Tracking started 21 Nov 2026; the change shows after 30 days.
Employees iTotal staff the company reported in its latest annual report (10-K), with the change from the year before when both years are reported.
–
No headcount in its annual reports in our data.
Visa hiring (foreign workers) iApplications to hire foreign specialists on H-1B and E-3 visas certified by the Labor Department in the last 12 months, compared with the 12 months before. This is NOT total hiring: most hires need no visa. Open jobs shows total hiring where we track it.
–
No data for this company
Revenue growth iSales in the latest reported quarter compared with the same quarter a year earlier.
-9.3%
$94.9M vs $104.6M (quarter ended 30 Sep 2026)
Capital spending iMoney spent on buildings, machines and equipment in the latest quarter, compared with the same quarter a year earlier.
–
No data for this company
Federal contracts iMoney the US government committed to the company in contracts and grants over the last 12 months.
–
No data for this company
Lobbying iWhat the company reported spending on federal lobbying over the last four quarters.
–
No data for this company
Layoff notices iWorkers named in state WARN layoff notices over the last 12 months (employers must file them 60 days before a large layoff).
–
No data for this company
News (7d) iArticles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.
12
12 articles in the last 7 days; its usual week has 1 (the median of the 26 weeks before).
News vs usual iArticles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.
12×
12 articles in the last 7 days; its usual week has 1.
Price $10.55 on 20 Nov 2026, +31% over 12 months (12-month range $4.48 to $12.22)
Sharp change
8-K and other filings
Insider net buying (open market). Insiders bought a net $0 in the last 12 months (the 12 months before: -$359K).Revenue per quarter. Revenue $94.9M in the latest quarter, -9.3% on a year earlier.Capital spending per quarter. Capital spending $770K in the latest quarter, +248% on a year earlier.Institutional holders (13F filers). 246 13F filers reported holding it in the latest 13F quarter, +7.4% on a year earlier.Federal obligations. Federal obligations: $1.8M published in the last 12 months (none in the 12 months before).
Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: h-1b/e-3 applications certified, lobbying spend, workers in warn layoff notices.
Quarter ended 31 Dec 2020: $64.6M; public on 2 Mar 2022
Quarter ended 31 Dec 2021: $75.3M, +17% on a year earlier; public on 2 Mar 2022
Quarter ended 31 Mar 2022: $81.6M, +22% on a year earlier; public on 6 May 2022
Quarter ended 30 Jun 2022: $82.8M, +18% on a year earlier; public on 10 Aug 2022
Quarter ended 30 Sep 2022: $84.7M, +15% on a year earlier; public on 8 Nov 2022
Quarter ended 31 Dec 2022: $86.6M, +15% on a year earlier; public on 2 Mar 2023
Quarter ended 31 Mar 2023: $90.3M, +11% on a year earlier; public on 9 May 2023
Quarter ended 30 Jun 2023: $90.5M, +9.3% on a year earlier; public on 10 Aug 2023
Quarter ended 30 Sep 2023: $85.6M, +1.0% on a year earlier; public on 9 Nov 2023
Quarter ended 31 Dec 2023: $88.0M, +1.6% on a year earlier; public on 1 Mar 2024
Quarter ended 31 Mar 2024: $96.7M, +7.0% on a year earlier; public on 8 May 2024
Quarter ended 30 Jun 2024: $93.3M, +3.2% on a year earlier; public on 7 Aug 2024
Quarter ended 30 Sep 2024: $94.8M, +11% on a year earlier; public on 7 Nov 2024
Quarter ended 31 Dec 2024: $100.4M, +14% on a year earlier; public on 27 Feb 2025
Quarter ended 31 Mar 2025: $106.0M, +9.7% on a year earlier; public on 6 May 2025
Quarter ended 30 Jun 2025: $104.6M, +12% on a year earlier; public on 7 Aug 2025
Quarter ended 30 Sep 2025: $104.6M, +10% on a year earlier; public on 7 Nov 2025
Quarter ended 31 Dec 2025: $103.6M, +3.3% on a year earlier; public on 27 Feb 2026
Quarter ended 31 Mar 2026: $106.9M, +0.9% on a year earlier; public on 12 May 2026
Quarter ended 30 Jun 2026: $93.3M, -11% on a year earlier; public on 5 Aug 2026
Quarter ended 30 Sep 2026: $94.9M, -9.3% on a year earlier; public on 6 Nov 2026
Capital spending per quarter
Quarter ended 31 Dec 2020: $81K; public on 2 Mar 2022
Quarter ended 31 Dec 2021: $148K, +83% on a year earlier; public on 2 Mar 2022
Quarter ended 31 Mar 2022: $506K, +128% on a year earlier; public on 6 May 2022
Quarter ended 30 Jun 2022: $353K, +22% on a year earlier; public on 10 Aug 2022
Quarter ended 30 Sep 2022: $390K, -19% on a year earlier; public on 8 Nov 2022
Quarter ended 31 Dec 2022: $181K, +22% on a year earlier; public on 2 Mar 2023
Quarter ended 31 Mar 2023: $317K, -37% on a year earlier; public on 9 May 2023
Quarter ended 30 Jun 2023: $271K, -23% on a year earlier; public on 10 Aug 2023
Quarter ended 30 Sep 2023: $311K, -20% on a year earlier; public on 9 Nov 2023
Quarter ended 31 Dec 2023: $878K, +385% on a year earlier; public on 1 Mar 2024
Quarter ended 31 Mar 2024: $619K, +95% on a year earlier; public on 8 May 2024
Quarter ended 30 Jun 2024: $427K, +58% on a year earlier; public on 7 Aug 2024
Quarter ended 30 Sep 2024: $164K, -47% on a year earlier; public on 7 Nov 2024
Quarter ended 31 Dec 2024: $415K, -53% on a year earlier; public on 27 Feb 2025
Quarter ended 31 Mar 2025: $600K, -3.1% on a year earlier; public on 6 May 2025
Quarter ended 30 Sep 2025: $221K, +35% on a year earlier; public on 7 Nov 2025
Quarter ended 31 Dec 2025: $1.0M, +142% on a year earlier; public on 27 Feb 2026
Quarter ended 31 Mar 2026: $631K, +5.2% on a year earlier; public on 12 May 2026
Quarter ended 30 Jun 2026: $621K; public on 5 Aug 2026
Quarter ended 30 Sep 2026: $770K, +248% on a year earlier; public on 6 Nov 2026
Institutional holders (13F filers)
31 Dec 2021 report: 148; public on 14 Feb 2022
31 Mar 2022 report: 157; public on 16 May 2022
30 Jun 2022 report: 156; public on 15 Aug 2022
30 Sep 2022 report: 172; public on 14 Nov 2022
31 Dec 2022 report: 186; public on 14 Feb 2023
31 Mar 2023 report: 203; public on 15 May 2023
30 Jun 2023 report: 193; public on 14 Aug 2023
30 Sep 2023 report: 184; public on 14 Nov 2023
31 Dec 2023 report: 198; public on 14 Feb 2024
31 Mar 2024 report: 209; public on 15 May 2024
30 Jun 2024 report: 208; public on 14 Aug 2024
30 Sep 2024 report: 218; public on 14 Nov 2024
31 Dec 2024 report: 220; public on 14 Feb 2025
31 Mar 2025 report: 238; public on 15 May 2025
30 Jun 2025 report: 227; public on 14 Aug 2025
30 Sep 2025 report: 229; public on 14 Nov 2025
31 Dec 2025 report: 247; public on 17 Feb 2026
31 Mar 2026 report: 251; public on 15 May 2026
30 Jun 2026 report: 237; public on 14 Aug 2026
30 Sep 2026 report: 246; public on 16 Nov 2026
Federal obligations
Month from 1 Feb 2022: $0 published
Month from 1 Mar 2022: $15K published
Month from 1 May 2022: $74K published
Month from 1 Jun 2022: $13K published
Month from 1 Jul 2022: $24K published
Month from 1 Sep 2022: $159K published
Month from 1 Jan 2023: $0 published
Month from 1 Mar 2023: $0 published
Month from 1 Apr 2023: $43K published
Month from 1 May 2023: $45K published
Month from 1 Jun 2023: $0 published
Month from 1 Jul 2023: $186K published
Month from 1 Aug 2023: $42K published
Month from 1 Sep 2023: $58K published
Month from 1 Oct 2023: $2K published
Month from 1 Jan 2024: $12K published
Month from 1 May 2024: $20K published
Month from 1 Jun 2024: $12K published
Month from 1 Jul 2024: $182K published
Month from 1 Aug 2024: $216K published
Month from 1 Mar 2026: $46K published
Month from 1 May 2026: $171K published
Month from 1 Jun 2026: -$22K published
Month from 1 Jul 2026: $175K published
Month from 1 Aug 2026: $350K published
Month from 1 Sep 2026: $1.1M published
What is unusual now
Nothing unusual in the last 90 days: no change appeared. Its most unusual measure now is insider open-market buying (USD, Form 4) at $200K (12 Nov 2025), higher than 97% of its own history.
53 open postings; careers site tracked since 21 Nov 2026. Most in Software engineering 19%, Sales & business development 15%, Research & science 11%, Legal, policy & compliance 8%.
Reported lobbying spend: $10K in Q4 2017, $10K in Q3 2017. Rows are lobbying firms hired or let go; amounts are reported per quarter, not per firm here.
had 13.4M shares sold short in the 29 Aug 2025 report, 2.5× the same report last year.
Same report last year: 5.3M; its normal report is 5.6M.
See the evidence
This period
13.4M (the 29 Aug 2025 report)
Normal report (median of 24 earlier)
5.6M
Typical spread (median absolute deviation)
1.4M
How far from its usual level
+3.7
Same report last year
5.3M
History used
1,718 days
the 29 Aug 2025 report24 earlier reportsnormal: 5.6M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 12.6M shares sold short in the 15 Aug 2025 report, 2.3× the same report last year.
Same report last year: 5.6M; its normal report is 5.5M.
See the evidence
This period
12.6M (the 15 Aug 2025 report)
Normal report (median of 24 earlier)
5.5M
Typical spread (median absolute deviation)
1.2M
How far from its usual level
+4.1
Same report last year
5.6M
History used
1,704 days
the 15 Aug 2025 report24 earlier reportsnormal: 5.5M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 11.2M shares sold short in the 31 Jul 2025 report, 2.2× the same report last year.
Same report last year: 5.0M; its normal report is 5.4M.
See the evidence
This period
11.2M (the 31 Jul 2025 report)
Normal report (median of 24 earlier)
5.4M
Typical spread (median absolute deviation)
986K
How far from its usual level
+4.0
Same report last year
5.0M
History used
1,689 days
the 31 Jul 2025 report24 earlier reportsnormal: 5.4M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 8.5M shares sold short in the 15 May 2025 report, 1.5× the same report last year.
Same report last year: 5.7M; its normal report is 5.1M.
See the evidence
This period
8.5M (the 15 May 2025 report)
Normal report (median of 24 earlier)
5.1M
Typical spread (median absolute deviation)
621K
How far from its usual level
+3.7
Same report last year
5.7M
History used
1,612 days
the 15 May 2025 report24 earlier reportsnormal: 5.1M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 9.4M shares sold short in the 30 Apr 2025 report, 1.7× the same report last year.
Same report last year: 5.7M; its normal report is 5.1M.
See the evidence
This period
9.4M (the 30 Apr 2025 report)
Normal report (median of 24 earlier)
5.1M
Typical spread (median absolute deviation)
559K
How far from its usual level
+5.2
Same report last year
5.7M
History used
1,597 days
the 30 Apr 2025 report24 earlier reportsnormal: 5.1M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 9.1M shares sold short in the 15 Apr 2025 report, 1.6× the same report last year.
Same report last year: 5.7M; its normal report is 5.1M.
See the evidence
This period
9.1M (the 15 Apr 2025 report)
Normal report (median of 24 earlier)
5.1M
Typical spread (median absolute deviation)
559K
How far from its usual level
+4.8
Same report last year
5.7M
History used
1,582 days
the 15 Apr 2025 report24 earlier reportsnormal: 5.1M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 7.1M shares sold short in the 31 Jul 2023 report, 2.8× the same report last year.
Same report last year: 2.6M; its normal report is 2.9M.
See the evidence
This period
7.1M (the 31 Jul 2023 report)
Normal report (median of 24 earlier)
2.9M
Typical spread (median absolute deviation)
651K
How far from its usual level
+4.4
Same report last year
2.6M
History used
958 days
the 31 Jul 2023 report24 earlier reportsnormal: 2.9M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 6.9M shares sold short in the 14 Jul 2023 report, 2.6× the same report last year.
Same report last year: 2.7M; its normal report is 2.9M.
See the evidence
This period
6.9M (the 14 Jul 2023 report)
Normal report (median of 24 earlier)
2.9M
Typical spread (median absolute deviation)
457K
How far from its usual level
+5.9
Same report last year
2.7M
History used
941 days
the 14 Jul 2023 report24 earlier reportsnormal: 2.9M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 7.8M shares sold short in the 30 Jun 2023 report, 2.7× the same report last year.
Same report last year: 2.8M; its normal report is 2.9M.
See the evidence
This period
7.8M (the 30 Jun 2023 report)
Normal report (median of 24 earlier)
2.9M
Typical spread (median absolute deviation)
310K
How far from its usual level
+10.7
Same report last year
2.8M
History used
927 days
the 30 Jun 2023 report24 earlier reportsnormal: 2.9M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 8.9M shares sold short in the 15 Jun 2023 report, 2.9× the same report last year.
Same report last year: 3.1M; its normal report is 2.9M.
See the evidence
This period
8.9M (the 15 Jun 2023 report)
Normal report (median of 24 earlier)
2.9M
Typical spread (median absolute deviation)
271K
How far from its usual level
+15.1
Same report last year
3.1M
History used
912 days
the 15 Jun 2023 report24 earlier reportsnormal: 2.9M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 10.4M shares sold short in the 31 May 2023 report, 2.8× the same report last year.
Same report last year: 3.7M; its normal report is 2.9M.
See the evidence
This period
10.4M (the 31 May 2023 report)
Normal report (median of 24 earlier)
2.9M
Typical spread (median absolute deviation)
271K
How far from its usual level
+18.7
Same report last year
3.7M
History used
897 days
the 31 May 2023 report24 earlier reportsnormal: 2.9M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 8.2M shares sold short in the 15 May 2023 report, 2.6× the same report last year.
Same report last year: 3.2M; its normal report is 2.9M.
See the evidence
This period
8.2M (the 15 May 2023 report)
Normal report (median of 24 earlier)
2.9M
Typical spread (median absolute deviation)
271K
How far from its usual level
+13.2
Same report last year
3.2M
History used
881 days
the 15 May 2023 report24 earlier reportsnormal: 2.9M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 8.0M shares sold short in the 28 Apr 2023 report, 2.3× the same report last year.
Same report last year: 3.4M; its normal report is 2.9M.
See the evidence
This period
8.0M (the 28 Apr 2023 report)
Normal report (median of 24 earlier)
2.9M
Typical spread (median absolute deviation)
271K
How far from its usual level
+12.9
Same report last year
3.4M
History used
864 days
the 28 Apr 2023 report24 earlier reportsnormal: 2.9M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 7.2M shares sold short in the 14 Apr 2023 report, 2.3× the same report last year.
Same report last year: 3.2M; its normal report is 2.9M.
See the evidence
This period
7.2M (the 14 Apr 2023 report)
Normal report (median of 24 earlier)
2.9M
Typical spread (median absolute deviation)
271K
How far from its usual level
+10.8
Same report last year
3.2M
History used
850 days
the 14 Apr 2023 report24 earlier reportsnormal: 2.9M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
had 7.4M shares sold short in the 31 Mar 2023 report, 2.6× the same report last year.
Same report last year: 2.8M; its normal report is 2.8M.
See the evidence
This period
7.4M (the 31 Mar 2023 report)
Normal report (median of 24 earlier)
2.8M
Typical spread (median absolute deviation)
249K
How far from its usual level
+12.5
Same report last year
2.8M
History used
836 days
the 31 Mar 2023 report24 earlier reportsnormal: 2.8M
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Fires on an 8-K with item 5.02 after 90 days without one.
Showing the newest 40 of 62 entries; narrow the window or the kind of data to see older ones.
Not listed: 160 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.
Identifiers and sources
How records are matched to this company, and what each source holds for it
Cik
0001827090
Ticker
CERT
Domain
certara.com
Employer name
certara usa (1 unverified)
Hq location
PA|RADNOR|19087 (1 unverified)
Lobbying client
certara
Name
Analytica LA-SER International, Inc, Applied BioMath, LLC, BioMedCom Consultants, Inc, Certara Australia Pty Ltd and 37 more